Global Multiple Sclerosis Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1602

Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Specific symptoms can include double vision, blindness in one eye, muscle weakness, trouble with sensation, or trouble with coordination. MS takes several forms, with new symptoms either occurring in isolated attacks (relapsing forms) or building up over time (progressive forms). Between attacks, symptoms may disappear completely; however, permanent neurological problems often remain, especially as the disease advances.
Although there is no known cure for multiple sclerosis, several therapies have proven helpful. The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. Starting medications is generally recommended in people after the first attack when more than two lesions are seen on MRI.
In 2018, the global Multiple Sclerosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Multiple Sclerosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Multiple Sclerosis Treatment development in United States, Europe and China.

The key players covered in this study
Teva Pharmaceutical Industries
Bayer
Biogen Idec
Pfizer
Novartis
...

Market segment by Type, the product can be split into
Immunomodulators
Immunosuppressant

Market segment by Application, split into
Veterinary Hospitals
Veterinary Clinics
Research Institutions

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Multiple Sclerosis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Multiple Sclerosis Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Multiple Sclerosis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Multiple Sclerosis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Immunomodulators
1.4.3 Immunosuppressant
1.5 Market by Application
1.5.1 Global Multiple Sclerosis Treatment Market Share by Application (2014-2025)
1.5.2 Veterinary Hospitals
1.5.3 Veterinary Clinics
1.5.4 Research Institutions
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Multiple Sclerosis Treatment Market Size
2.2 Multiple Sclerosis Treatment Growth Trends by Regions
2.2.1 Multiple Sclerosis Treatment Market Size by Regions (2014-2025)
2.2.2 Multiple Sclerosis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Multiple Sclerosis Treatment Market Size by Manufacturers
3.1.1 Global Multiple Sclerosis Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Multiple Sclerosis Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Multiple Sclerosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Multiple Sclerosis Treatment Key Players Head office and Area Served
3.3 Key Players Multiple Sclerosis Treatment Product/Solution/Service
3.4 Date of Enter into Multiple Sclerosis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Multiple Sclerosis Treatment Market Size by Type (2014-2019)
4.2 Global Multiple Sclerosis Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Multiple Sclerosis Treatment Market Size (2014-2019)
5.2 Multiple Sclerosis Treatment Key Players in United States
5.3 United States Multiple Sclerosis Treatment Market Size by Type
5.4 United States Multiple Sclerosis Treatment Market Size by Application

6 Europe
6.1 Europe Multiple Sclerosis Treatment Market Size (2014-2019)
6.2 Multiple Sclerosis Treatment Key Players in Europe
6.3 Europe Multiple Sclerosis Treatment Market Size by Type
6.4 Europe Multiple Sclerosis Treatment Market Size by Application

7 China
7.1 China Multiple Sclerosis Treatment Market Size (2014-2019)
7.2 Multiple Sclerosis Treatment Key Players in China
7.3 China Multiple Sclerosis Treatment Market Size by Type
7.4 China Multiple Sclerosis Treatment Market Size by Application

8 Japan
8.1 Japan Multiple Sclerosis Treatment Market Size (2014-2019)
8.2 Multiple Sclerosis Treatment Key Players in Japan
8.3 Japan Multiple Sclerosis Treatment Market Size by Type
8.4 Japan Multiple Sclerosis Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Multiple Sclerosis Treatment Market Size (2014-2019)
9.2 Multiple Sclerosis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Multiple Sclerosis Treatment Market Size by Type
9.4 Southeast Asia Multiple Sclerosis Treatment Market Size by Application

10 India
10.1 India Multiple Sclerosis Treatment Market Size (2014-2019)
10.2 Multiple Sclerosis Treatment Key Players in India
10.3 India Multiple Sclerosis Treatment Market Size by Type
10.4 India Multiple Sclerosis Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Multiple Sclerosis Treatment Market Size (2014-2019)
11.2 Multiple Sclerosis Treatment Key Players in Central & South America
11.3 Central & South America Multiple Sclerosis Treatment Market Size by Type
11.4 Central & South America Multiple Sclerosis Treatment Market Size by Application

12 International Players Profiles
12.1 Teva Pharmaceutical Industries
12.1.1 Teva Pharmaceutical Industries Company Details
12.1.2 Company Description and Business Overview
12.1.3 Multiple Sclerosis Treatment Introduction
12.1.4 Teva Pharmaceutical Industries Revenue in Multiple Sclerosis Treatment Business (2014-2019)
12.1.5 Teva Pharmaceutical Industries Recent Development
12.2 Bayer
12.2.1 Bayer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Multiple Sclerosis Treatment Introduction
12.2.4 Bayer Revenue in Multiple Sclerosis Treatment Business (2014-2019)
12.2.5 Bayer Recent Development
12.3 Biogen Idec
12.3.1 Biogen Idec Company Details
12.3.2 Company Description and Business Overview
12.3.3 Multiple Sclerosis Treatment Introduction
12.3.4 Biogen Idec Revenue in Multiple Sclerosis Treatment Business (2014-2019)
12.3.5 Biogen Idec Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Multiple Sclerosis Treatment Introduction
12.4.4 Pfizer Revenue in Multiple Sclerosis Treatment Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Multiple Sclerosis Treatment Introduction
12.5.4 Novartis Revenue in Multiple Sclerosis Treatment Business (2014-2019)
12.5.5 Novartis Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details